The goal of treatment in osteoarthritis is to reduce joint pain and inflammation while improving and maintaining joint function. Developed in Japan, LOCOA® is a tape type patch with COX inhibition that is used to treat inflammation and pain for osteoarthritis.
Besides resting, stretching, weight loss management, physical therapy, occupational therapy or mechanical support devices, such as knee braces, osteoarthritis patients have an option with LOCOA® to manage their pain.
LOCOA® is proven to be safe on having a safety study based on a 52-weeks treatment and has minimal Adverse Drug Reactions (ADR). LOCOA® has a daily dosing of one patch only as the plasma concentration is well maintained throughout 24 hours.
Mr. Tomoyuki Katsuta said that their hope is that patients who are on LOCOA® will be able to live their day-to-day life close to normal again without having to bear much pain. He also highlighted that the launch of LOCOA® in Kuala Lumpur is timely with the upcoming World Arthritis Day 2021 on October 12th, 2021.
It is worth noting that Taisho Pharmaceutical has decided to choose Malaysia as the first country outside Japan to introduce LOCOA®. According to the Department of Statistics Malaysia (DOSM), the number of people aged 65 years and above in Malaysia has increased steadily since the 1970s. Seeing the potential of Malaysia to be a country with high level of health consciousness, Taisho Pharmaceutical believes by introducing LOCOA® here, it would also benefit elderly Malaysian population.
About
Taisho Pharmaceutical Co. Ltd
Taisho Pharmaceutical Co. Ltd
is one of the leading pharmaceutical companies in Japan, has acquired HOE
Pharmaceuticals in 2011. This acquisition strengthens the business in Malaysia
and the growing Asian markets. The Company’s mission in its philosophy is to
contribute to society by creating and offering top-quality
pharmaceuticals and health-related products, as well as healthcare-related
information and services in socially responsible ways that enrich people’s
lives by improving health and beauty.
Being the foundation of all
its corporate activities, Taisho recognizes that, more than ever, it is
following in the tradition of SHINSHO (gentlemanship in business, in accordance
with high social ethics), a phrase often quoted by the Company’s first honorary
chairman, the late Shokichi Uehara. By keeping the SHINSHO business constantly
in mind, and with an earnest desire to work for the consumers, it is Taisho’s
intention to adhere strictly to its philosophy, and strives to contribute to
all fields related to healthcare.
KKLIU 2358/2021
0 comments:
Post a Comment